chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per Regulatory Authority it is to be reported if patient gets COVID if fully vaccinated.  Per MD note 1.  Acute hypoxemic respiratory failure:  This is in a patient with COVID pneumonia.  The patient was placed on supplemental oxygen.  The plan is for the patient to use supplemental oxygen with oxygen by nasal cannula up to 6 L and if oxygen saturation falls below 90% on 6 L oxygen by nasal cannula, he will be transitioned to high-flow oxygen.  However, if he is on maximal support with high-flow oxygen with oxygen saturation falling below 90%, the patient should be placed on BiPAP and transferred to the ICU.  The patient is a full code. 2.  COVID pneumonia:  This in a patient who apparently received his Johnson and Johnson COVID vaccine 3 weeks ago.  The patient started on treatment with remdesivir.  He will get steroids.  He is prescribed Tessalon Perles and Robitussin with codeine as needed for coughing.  He may be considered for potentially other treatments in the setting of his COVID pneumonia, especially if his respiratory status deteriorates.  We will closely follow up in the COVID unit after admission. 3.  Alteration of mental status and encephalopathy:  This in a patient who is hypoglycemic.  However, part of his encephalopathy related to his COVID infection and volume depletion.  He is being volume repleted and treated for his condition.  He will have frequent neurologic checks done after admission. 4.  Generalized weakness and deconditioning:  This is in a volume depleted patient with COVID.  His COVID will be appropriately treated and he will be volume repleted.  He will need to work with physical and occupational therapy towards the end of the hospitalization. 5.  Congestive heart failure, systolic plus diastolic dysfunction:  The patient does not have any evidence of acute congestive heart failure at the moment.  However, we will take care to prevent volume overload in this patient, who requires volume repletion in the setting of his volume depletion. 6.  Volume depletion:  The patient will get another liter of IV fluids after admission at 80 mL per hour as tolerated.  The goal is to avoid excessive IV fluid administration in this patient with COVID pneumonia.
Nausea, headache, sinus pain, extreme fatigue,  dizziness, disorientation, brain fog, blurred vision and chills. Symptoms started 5 minutes after injection and were in full effect within 30 minutes.  29 hours later they are still continuing. Unable to function and no idea how long symptoms will last.
After noticing  getting the 2nd flu influenza shot in Dec 2020. My son started getting this eczema like bumps inside his  bot of his arms like 2 to 3 three weeks later.  He also got an Rash and started scratching over his both lateral arms, backs, legs, and neck so we started applying  hydrocortisone cream and  Aquaphor cream on him. We also went to his physician in August 2020 and to see about getting an stronger cream for him.  We also switch laundry detergent and switch to a new product shampoo since using products. But his eczema is still there.
Patient was given MENACTRA 8/20/08 based on what I thought was complete immunization record of past history. Today he received other immunization information that patient had received MENACTRA at a different clinic on 4/11/08. I called to discuss with CDC who said no serious side effects expected but they asked me to fill out VAER form.
THE VANISHING POINT NEEDLE MALFUNCTIONED AND SPILLED MOST IF NOT ALL OF THE VACCINE ALL DOWN HER ARM.    I DISCUSSED WITH PATIENT AND WE AGREED THAT NOT ENOUGH VACCINE WAS ADMININSTERED TO COUNT AS A DOSE SO WE REPEATED THE VACCINE.    VANISHING POING SYRINGE 1ML 25G1" REF10161 LOT G210865 7.28.2006 10(G210862 (17) 260728
Left humoral, radial ulnar nerve pain/weakness for last 11 days. Loss of strength in left arm. At times extreme pain on rotation.
my knee swelled up; knee started bothering; swollen; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (my knee swelled up), ARTHRALGIA (knee started bothering) and SWELLING (swollen) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced JOINT SWELLING (my knee swelled up), ARTHRALGIA (knee started bothering) and SWELLING (swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, JOINT SWELLING (my knee swelled up), ARTHRALGIA (knee started bothering) and SWELLING (swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
(L) upper arm - redness around entire upper arm - swollen - pt. is tired, unable to concentrate and leg pain bilaterally.
pt recv vax; rash on legs and arms and torso; was prescribed claritin;
pt recv vax & fainted on 1st flight of stairs & hit chin & had sl abrasion on rt forearm;pt attempted to do down 2nd flight of stairs & had fallen down;pt was clammy, pale;bruise observed under chin;BP 94/68, P60, R20;devel bump on head
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored LIQUID PEDVAXHIB (strength, dose and route of administration were not reported) of lot # N000237, expiration date 25-OCT-2019, for prophylaxis. The vaccine was exposed to 0 degree celcius to 1 degree celcius for 21 minutes (incorrect product storage). There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported. There was no product quality complaint(PQC) involved. This is one of the two reports received from same reporter.; Sender's Comments:  US-009507513-1708USA005432:
10/14/09 Immunization given - no adverse effects. 10/20/09 upon arising - discomfort /stiffness of right deltoid- entire muscle, more evident with movement.
given a second dose of Adacel with no adverse event; pregnant female was "unexpectedly, in error" given a second dose of Adacel; Initial information was received on 15-Oct-2020 regarding an unsolicited valid non-serious case from the other health professional.  This case involves a 30 year old female patient who was pregnant and was unexpectedly, in error, given a second dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (extra dose administered and Vaccine exposure during pregnancy).  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. It was reported that the patient was exposed to the vaccine at 29 weeks of pregnancy and had given a second dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE on 34 weeks of pregnancy.  The date of the last menstrual period was reported as 15-Feb-2020.  The estimated due date is 21-Nov-2020.  Medical history, medical treatments, vaccinations and family history were not provided. It was a potential medication error due to an extra dose being administered. Concomitant medications included INFLUENZA VACCINE INACT SPLIT 3V (FLULAVAL) for immunisation.  On 31-Aug-2020, the patient received 1 dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number U6676AA expiration date 16-May-2022) via intramuscular route in the right deltoid muscle for immunization during the 29 weeks of pregnancy (vaccine exposure during pregnancy).   On 13-Oct-2020, 1 month 15 days after the first dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE unexpectedly, in error, the patient was given the second dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE and asked if there were any possible side effects or concerns that they should look out for.   The healthcare professional stated that the 30 year old pregnant female patient was given a second DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE dose on 13-Oct-2020. The patient's first dose of vaccine was given on 31-Aug-2020. The physician, did not realize that the patient had already received the DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE and wrote a prescription for patient to receive vaccination on 13-Oct-2020.   It was discovered after DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE that this was actually the second DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as not applicable for both the events.
Well I received my first series anthrax shot on the26th of Dec. 2002 and I felt worn out after it.I received my second series shot yesterday on the 9th of Jan 2003 and not only do I feel worn out I feel pain.I have pain in my back of my left shoulder and in my left lung and something that almost feels like my liver.It hurts to breathe in.
pt recv vax & called MD 16APR98 & reported cellulitis like sx  lt arm & sent to ER for tx as MD office closed @ that time;pt was given duricef & rechecked on 18APR98 in ER;20APR98 much better dec swelling, no redness, sl tenderness;
Information has been received from a physician concerning a 16 month old previously healthy male with no past medical history, including chickenpox, and no concurrent conditions who on 27AUG2003 was vaccinated SC in the right arm with 0.5ml dose of varicella virus vaccine live. It was also reported that the child "was vaccinated at approximately 18 months of age". There was no concomitant medication. There was no recent known exposure to wild type VZV. The physician indicated that the patient developed a breakthrough varicella. On 29DEC2003 through 01JAN2004 the patient developed approximately 12 to 14 lesions. On 09JAN2004, the child was in the office again and continued to develop lesions. The child's mother indicated that patches of lesions were "still popping up in various places". Unspecified medical attention was sought. There was no product quality complaint. No laboratory diagnostic studies were performed. Follow up information received from the physician indicated that the rash did not occur at the site of injection post-vaccination. The patient's maximum temperature was 103 degrees Fahrenheit. Other systemic symptoms included pruritus. The type of adverse experience was a rash that was a papule, vesicle and crust. It was noted to be "varicella".  The child had no recent exposure to chickenpox or shingles. Additional follow up information received on 23JAN2004 indicated that the specimen received for PCR analysis was inadequate (large dry swab sent). Follow up information indicated that the specimen was obtained on 13JAN2004 and sent to the laboratory 13JAN2004. The VZV DNA was not amplified. The B globin DNA was not amplified. The interpretation was inadequate specimen, negative for B globin and not strain ID. Additional follow up information indicated that the patient had been seen by a dermatologist and the diagnosis is not varicella. No other information was available. No further information is expected.
2 patients (16 year old female and 12 year old male) were accidentally given the second dose of the vaccine on 04JUN2021, 15 days after the first dose.; swollen lymph node in her armpit; This is a spontaneous report from a contactable pharmacist. A 16-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration on 04Jun2021 as DOSE 2, SINGLE for Covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 04jun2021, 15 days after the first dose the patient experienced 2 patients (16 year old female and 12 year old male) were accidentally given the second dose of the vaccine, on 04Jun2021 with outcome of unknown, swollen lymph node in her armpit. The with outcome of events was unknown.  Information on the lot/batch number has been requested.
Lower abdominal pain; ringing in ears; aching joints, frontal headache, very tired/Felt like the worst flu ever; This is a spontaneous report from a contactable healthcare professional (patient). This 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283 and expiry date unknown), via an unspecified route of administration on 13Jan2021 10:30 at a single dose on the right arm for COVID-19 immunization. Medical history included asthma and allergies: sulfa drugs. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did fine until 23Jan2021 09:00 through 25Jan2021 as the patient experienced lower abdominal pain, aching joints, frontal headache, ringing in ears, and very tired. The patient stated that it felt like the worst flu ever. He also stated that his concern was will it be worse on the second injection. He may not take it. Events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received. Outcome of the events was recovering.
Pt had fever, nausea/vomiting, body ache and pain. "FEEL LIKE HAVING A PNEUMONIA"
Fever, chills, exteme fatigue, nausea, vomiting, abdominal pain, diarrhea.
Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: light headed, sweaty, notable to respond verbally, closing eyes, unable to sit up by himself, pressure in ears. Paramedic team came. Patient recovered. Patient does not need to go to the hospital.
allergy; Initial information received on 11-May-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 76 years old male patient who experienced allergy while receiving vaccine Tetanus Toxoid.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect Tetanus Toxoid produced by unknown manufacturer with unknown formulation, strength, batch number & expiry date via unknown route in unknown administration site for Tetanus immunisation. Information on the batch number was requested.  On an unknown date the patient developed allergy (hypersensitivity) (unknown latency) following the administration of Tetanus Toxoid.  It is unknown if the patient experienced any additional symptoms/events.   It is unknown if there were lab data/results available.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was Unknown.
MMR and Varicella Immunizations erroneously diluted with 0.9 Normal Saline not sterile water.
Very sore arm, swelling, redness and warmth at injection site, fatigue, nausea feeling
Information has been received from a registered nurse concerning a female who was vaccinated with GARDASIL.  Subsequently, reported on 20-AUG-2007 that "in the past few months", the patient fainted.  Subsequently, after ten minutes of lying down, the patient recovered from fainting.  This is one of several reports received from the same source.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 9/17/2007. Information has been received from a physician concerning a 13 year old female patient with a history of almost fainting about once a month, who on 27-JUN-2007, was vaccinated IM into the left arm with a dose of GARDASIL (Lot# 657737/0522U). After getting the vaccine, the patient felt light headed and dizzy. It was reported that it got worse when she sat up or stood up. The patient's blood pressure decreased to 98/58. The patient left the office after about 50 minutes when she was feeling better. Another physician was consulted before discharging the patient home. On 27-JUN-2007, the patient recovered from lightheaded and dizzy. On an unspecified date, the patient recovered from fainting. Additional information is not expected.
pt reports reddness & swelling of lt arm surrounding inject site; seen by allergist MD put on steroids;
Fever, dizziness, headaches, back pain, nausea, swelling of abdomen, extreme weakness, unable to eat whole foods (currently only eating yogurt and jello), constant UTI's and pancreatic issues, weight loss, rash, dehydration, unable to stand, random fainting, loss of consciousness, peeling of the skin(legs, feet, arms, hands).  Healthcare providers has not diagnosed patient.
Information has been received from a nurse concerning a 10 year old female who on 17-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 656079/1306F). On 18-JUL-2007 the patient developed a rash all over, a four inch round red spot around the injection site, a fever of 99-100, and weakness, especially in her legs. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. Follow-up information received stated that the patient was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) on 18-JUL-2007 in the left arm. There was no illness at the time of vaccination. On 18-JUL-2007, the patient developed a 3X3 indurated area that was red and swollen at the injection site. The patient complained of weakness in the legs, and achy arms. Cellulitis developed and the patient was treated with cephalexin (KEFLEX) 500mg three times a day. The patient did not have a rash. No laboratory or diagnostic tests were performed. Subsequently, the patient recovered.
SENSITIVE POINT AT INJECTION SITE; This spontaneous report received from a consumer concerned a 75 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 for covid-19 prophylaxis. Age at time of vaccination 75 years old. No concomitant medications were reported. On MAR-2021, the patient experienced sensitive point at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sensitive point at injection site on 07-MAR-2021. This report was non-serious.
The evening of the vaccine I got fever and chills. The next morning, I woke up with the worse headache ever. I took Tylenol which didn't help. I laid in a dark room and couldn't do anything. I called my doctor that morning to see if I could take anything other than Tylenol and they said no. By that evening the headache lessened and was gone by the next day.
Flu shot administered in left shoulder joint line per employee. Pain in left shoulder since flu shot given.
Left thigh with 2cm induration; 1.3x1.5cm erythema, warm, non-tender at site of immunization injection, warm compress applied.
I got feeling tired early in the evening plus achy in the middle of the night, I woke up drenched in sweat and the next morning I was still achy and weak feeling. I received a MAB infusion and this sickness lasted approximately four days.
Fever of 101 degrees F, nausea and vomiting, headache, congestion, fatigue
Was 200 lbs, but he went down to 181 lbs after getting covid; He got much sicker; This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (He got much sicker) and WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced ILLNESS (He got much sicker). On an unknown date, the patient experienced WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, ILLNESS (He got much sicker) had not resolved and WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, COVID-19: positive (Positive) tested positive for covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.   This case was linked to MOD-2021-014947 (Patient Link).
pt recv vax; lt sided facial paralysis; lt eyelid did not close; no pain, no fever;
p/vax pt exp an inj site rxn characterized by pain, swelling, hardness, & erythema which measured 3 inches by 4 inches;also exp ecchymosis @ the inj site, transient jaw tightness & gen aches & pains x 1 day;
Patient received pneumonia vaccine that resulted in the patient complaining of discomfort in her left upper arm.  The nurse checked and found a 8cm x 6 cm hive with reddish area in the middle.  Denied itching or SOB.  Over the following 2 days, the local reaction grew to encompass the entire upper left arm radiating to the forearm. Records received and reviewed for DOS 01/07-01/12/07 DC DX: upper respiratory tract infection Bronchitis Chronic atrial fibrillation Gastroesophageal reflux disease Adverse reaction to pneumococcal vaccine. Admitted to hospital with increasing cough and chest tightness, hypoxemia and tachycardia. After receiving pneumovax vaccine her arm became acutely swollen and tender and the area of erythema and induration spread to involve the upper arm onto the chest wall extending distal beyond the elbow towards the hand. Spiked temperatures up to 101 to 102 on 2 occasions.
Information has been received from a consumer concerning her daughter, a 14 year old female who in August 2007, was vaccinated with her first dose of Gardasil vaccine. The consumer reported that her daughter missed the second dose about a week ago and that her daughter experienced hot flashes after receiving the first dose. No lot number was provided. additional information has been requested.
Information has been received from a medical assistant referring to a 4 years old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 23-JUN-2015, the patient was vaccinated with an improperly stored doses of MMR II (lot # K021151 with expiration date 02-NOV-2016; dose and route of administration were not reported). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
12:01p complained of headache, lungs checked R upper lobe rattle on chest no respiratory distress. No fever. Notified aunt. 1225 Aunt came to take her home to give her nebulizer treatment. Instructed if she continues to rattle on chest she should see MD.
patient said arm started to itch and was red/swollen in the injection area 2 days post vaccination.  She said she went out to clear snow and when she came back in the house the symptoms started.
The injection site is itchy and splotchy however this was not a symptom until after a week of getting the shot. My arm is the only area of this rash like symptom. NO fever after injection has occurred. My arm is warmer to the touch than the other arm. I have taken progression pictures if needed to be emailed and dated. I have taken benedryl after I noticed the rash and seemed to have no changes.